>
Switch to:

BridgeBio Pharma EV-to-Revenue

: 380.54 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BridgeBio Pharma's enterprise value is $8,351.41 Mil. BridgeBio Pharma's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was $21.95 Mil. Therefore, BridgeBio Pharma's EV-to-Revenue for today is 380.54.

NAS:BBIO' s EV-to-Revenue Range Over the Past 10 Years
Min: 55.6   Med: 90.6   Max: 374.9
Current: 380.54

55.6
374.9

During the past 3 years, the highest EV-to-Revenue of BridgeBio Pharma was 374.90. The lowest was 55.60. And the median was 90.60.

NAS:BBIO's EV-to-Revenue is ranked lower than
84% of the 910 Companies
in the Biotechnology industry.

( Industry Median: 23.05 vs. NAS:BBIO: 380.54 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-01-23), BridgeBio Pharma's stock price is $69.480000. BridgeBio Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.19. Therefore, BridgeBio Pharma's PS Ratio for today is 373.55.


BridgeBio Pharma EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
EV-to-Revenue 0.00 0.00 97.27

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.30 97.27 75.25 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


BridgeBio Pharma EV-to-Revenue Distribution

* The bar in red indicates where BridgeBio Pharma's EV-to-Revenue falls into.



BridgeBio Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BridgeBio Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8351.405/21.946
=380.54

BridgeBio Pharma's current Enterprise Value is $8,351.41 Mil.
BridgeBio Pharma's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was 13.819 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 8.127 (Sep. 2020 ) = $21.95 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


BridgeBio Pharma  (NAS:BBIO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BridgeBio Pharma's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=69.480000/0.186
=373.55

BridgeBio Pharma's share price for today is $69.480000.
BridgeBio Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 0.117 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0.069 (Sep. 2020 ) = $0.19.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


BridgeBio Pharma EV-to-Revenue Related Terms


BridgeBio Pharma EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)